SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Medicine Man Technologies, Inc. (SHWZ) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 40/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SHWZ
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.26
Book Value / Share$0.00
Revenue / Share$2.67
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$0.00 |
$251.89K |
$-29.95K |
-11.9% |
| 2015 |
$0.01 |
$835.78K |
$85.75K |
10.3% |
| 2016 |
$-0.14 |
$631.46K |
$-1.46M |
-231.9% |
| 2017 |
$-0.23 |
$3.53M |
$-5.38M |
-152.5% |
| 2018 |
$0.03 |
$7.92M |
$948.92K |
12% |
| 2019 |
$-0.50 |
$10.62M |
$-16.98M |
-159.9% |
| 2020 |
$-0.47 |
$24M |
$-19.42M |
-80.9% |
| 2021 |
$-0.06 |
$108.42M |
$14.52M |
13.4% |
| 2022 |
$-0.34 |
$159.38M |
$-18.47M |
-11.6% |
| 2023 |
$-0.26 |
$172.45M |
$-34.55M |
-20% |
